Common use of Publication Rights Clause in Contracts

Publication Rights. Each Party shall submit to the other Party for review and approval all proposed academic, scientific and medical publications and public presentations relating to any activities under this Agreement for review in connection with preservation of Patent Rights and trade secrets or to determine whether Confidential Information should be modified or deleted from the proposed publication or public presentation. Written copies of such proposed publications and presentations shall be submitted to the non-publishing or non-presenting Party no later than […***…] days before the planned submission for publication or presentation and the non-publishing or non-presenting Party shall provide its comments with respect to such publications and presentations within […***…] days after its receipt of such written copy. The review period may be extended for an additional […***…] days if the non-publishing or non-presenting Party can demonstrate a reasonable need for such extension including, without limitation, the preparation and filing of patent applications (which extension shall not be unreasonably withheld or delayed). By written agreement, this period may be further extended (which extension shall not be unreasonably withheld or delayed). Without limiting the foregoing, no publication or presentation shall be made unless and until the non-publishing or non-presenting Party ‘s reasonable comments on the proposed publication or presentation have been addressed and any information has been removed that is determined by the non-publishing or non-presenting Party to be its Confidential Information or that the non-publishing or non-presenting Party desires to maintain in secrecy to preserve the value of its rights under this Agreement. The Parties will each comply with standard academic practice regarding authorship of scientific publications or presentations and recognition of contribution of other Persons in any publications or presentations relating to a Licensed Product and/or Selected Compound or any discovery, research or Development activities under this Agreement.

Publication Rights. Each Until the first anniversary of the Effective Date, the following restrictions shall apply with respect to possible disclosure by either Party of the other Party’s Confidential Information relating to Licensed Products in any publication or presentation. A Party (the “Publishing Party”) shall submit to provide the other Party with a copy of any proposed publication or presentation at least 30 days before submission for review and approval all proposed academic, scientific and medical publications and public presentations relating publication by the Publishing Party or its Affiliates so as to provide such other Party with an opportunity to recommend any activities under this Agreement for review in connection with preservation of Patent Rights and trade secrets or changes it reasonably believes are necessary to determine whether continue to maintain the Confidential Information should disclosed by the other Party to the Publishing Party in accordance with the requirements of this Agreement. The incorporation of such recommended changes shall not be modified or deleted from unreasonably refused; and if such other Party notifies (“Notice”) the Publishing Party in writing, within 30 days after receipt of the copy of the proposed publication or public presentation, that such publication or presentation in its reasonable judgment (a) contains an invention, solely or jointly conceived or reduced to practice by the other Party, for which the other Party reasonably desires to obtain patent protection or (b) could be expected to have a material adverse effect on the commercial value of any Confidential Information disclosed by the other Party to the Publishing Party, the Publishing Party shall prevent such publication or delay such publication for a mutually agreeable period of time. Written copies In the case of such proposed publications and presentations inventions, a delay shall be submitted for a period reasonably sufficient to permit the timely preparation and filing of a patent application(s) on such invention, and in no event less than 90 days after the date of the Notice. In the case of Confidential Information, any of the non-publishing or non-presenting Party no later than […***…] days before the planned submission for publication or presentation and the non-publishing or non-presenting Party Party’s Confidential Information shall provide its comments with respect to such publications and presentations within […***…] days after its receipt of such written copybe deleted as requested. The review period may be extended for an additional […***…] days if Parties hereby agree that the non-publishing or non-presenting Party can demonstrate a reasonable need for such extension includingpublication review may diminish over time and agree, without limitationevery six months, to discuss and attempt to agree upon whether and/or when the preparation and filing of patent applications (which extension shall not be unreasonably withheld or delayed). By written agreement, obligations under this period Section 7.6 may be further extended (which extension shall not be unreasonably withheld or delayed). Without limiting the foregoing, no publication or presentation shall be made unless and until the non-publishing or non-presenting Party ‘s reasonable comments on the proposed publication or presentation have been addressed and any information has been removed that is determined by the non-publishing or non-presenting Party to be its Confidential Information or that the non-publishing or non-presenting Party desires to maintain in secrecy to preserve the value of its rights under this Agreement. The Parties will each comply with standard academic practice regarding authorship of scientific publications or presentations and recognition of contribution of other Persons in any publications or presentations relating to a Licensed Product and/or Selected Compound or any discovery, research or Development activities under this Agreementdiscontinued.

Publication Rights. Each During the Term, the following restrictions shall apply with respect to possible disclosure by any Party of any other Party’s Confidential Information relating to Licensed Products in any publication or presentation. A Party (the “Publishing Party”) shall submit to provide the other Party with a copy of any proposed publication or presentation at least 30 days before submission for review and approval all proposed academic, scientific and medical publications and public presentations relating publication by the Publishing Party or its Affiliates so as to provide such other Party with an opportunity to recommend any activities under this Agreement for review in connection with preservation of Patent Rights and trade secrets or changes it reasonably believes are necessary to determine whether continue to maintain the Confidential Information should disclosed by the other Party to the Publishing Party in accordance with the requirements of this Agreement. The incorporation of such recommended changes shall not be modified or deleted from unreasonably refused; and if such other Party notifies (“Notice”) the Publishing Party in writing, within 30 days after receipt of the copy of the proposed publication or public presentation, that such publication or presentation in its reasonable judgment (a) contains an invention, solely or jointly conceived or reduced to practice by the other Party, for which the other Party reasonably desires to obtain patent protection or (b) could be expected to have a material adverse effect on the commercial value of any Confidential Information disclosed by the other Party to the Publishing Party, the Publishing Party shall prevent such publication or delay such publication for a mutually agreeable period of time. Written copies In the case of such proposed publications and presentations inventions, a delay shall be submitted for a period reasonably sufficient to permit the timely preparation and filing of a patent application(s) on such invention, and in no event less than 90 days after the date of the Notice. In the case of Confidential Information, any of the non-publishing or non-presenting Party no later than […***…] days before the planned submission for publication or presentation and the non-publishing or non-presenting Party Party’s Confidential Information shall provide its comments with respect to such publications and presentations within […***…] days after its receipt of such written copybe deleted as requested. The review period may be extended for an additional […***…] days if Parties hereby agree that the non-publishing or non-presenting Party can demonstrate a reasonable need for such extension includingpublication review may diminish over time and agree, without limitationevery six months, to discuss and attempt to agree upon whether and/or when the preparation and filing of patent applications (which extension shall not be unreasonably withheld or delayed). By written agreement, obligations under this period Section 8.6 may be further extended (which extension shall not be unreasonably withheld or delayed). Without limiting the foregoing, no publication or presentation shall be made unless and until the non-publishing or non-presenting Party ‘s reasonable comments on the proposed publication or presentation have been addressed and any information has been removed that is determined by the non-publishing or non-presenting Party to be its Confidential Information or that the non-publishing or non-presenting Party desires to maintain in secrecy to preserve the value of its rights under this Agreement. The Parties will each comply with standard academic practice regarding authorship of scientific publications or presentations and recognition of contribution of other Persons in any publications or presentations relating to a Licensed Product and/or Selected Compound or any discovery, research or Development activities under this Agreementdiscontinued.

Publication Rights. Each 9.4.1 [***], neither Party will make any Publication disclosing any Results [***] review in accordance with Section 9.4.5. 9.4.2 [***], neither Party will make any Publication disclosing the Results [***] or any results, data or finding generated pursuant to the Evaluation Program [***], in each case, [***] review in accordance with Section 9.4.5. 9.4.3 [***], (a) Spark shall submit have the right to make Publications disclosing the Results [***], any results, data or finding generated pursuant to the Evaluation Program [***] or the Development, Manufacturing, Commercialization or other exploitation of Products [***] in the Licensed Field in the Territory under this Agreement, [***] review in accordance with Section 9.4.5 and (b) Senti shall have the right to make Publications disclosing the Development, Manufacturing, Commercialization or other exploitation of (i) Products [***] outside the Licensed Field in the Territory and (ii) products [***] that are not Products, in each case, [***] review in accordance with Section 9.4.5. 9.4.4 [***], Senti shall have the right to make Publications disclosing the Results [***] or any results, data or finding generated pursuant to the Evaluation Program [***] review in accordance with Section 9.4.5 ([***]). 9.4.5 If either Party intends to make a Publication described in Sections 9.4.1-9.4.4, such Party (the “Publishing Party”) shall provide the other Party for review and approval all proposed academic, scientific and medical publications and public presentations relating to any activities under this Agreement for review in connection (the “Non-Publishing Party”) with preservation of Patent Rights and trade secrets or to determine whether Confidential Information should be modified or deleted from the proposed publication or public presentation. Written copies of such proposed publications and presentations shall be submitted to the non-publishing or non-presenting Party no later than Publication at least […***…] days before prior to the planned intended submission for publication or presentation date, whichever is sooner. The Non-Publishing Party will have the right to reasonably review and comment to such Publication and the non-publishing or non-presenting Publishing Party shall provide its in good faith consider any comments made by the Non-Publishing Party in such [***] period. If such Publication contains Confidential Information of the Non-Publishing Party, then upon the Non-Publishing Party’s request during such [***] period, the Publishing Party shall delete any such information identified by the Non-Publishing Party. If the Non-Publishing Party wishes to request a reasonable delay of the Publication in order to protect patentable information, the Publishing Party shall delay the Publication for a period of no more than [***] to enable patent applications to be filed in accordance with ARTICLE 8 to protect any intellectual property rights disclosed in such Publication. For clarity, if the Non-Publishing Party fails to notify the Publishing Party during the [***] previewing period as provided under this Section 9.4.5, the Publishing Party shall be free to proceed with the proposed Publication. 9.4.6 For the avoidance of doubt, this Section 9.4 shall in no way prohibit (a) Spark from making Publications with respect to such publications and presentations within […***…] days after its receipt of such written copy. The review period may be extended for an additional […***…] days if the non-publishing or non-presenting Party can demonstrate a reasonable need for such extension including, without limitation, the preparation and filing of patent applications (which extension shall not be unreasonably withheld or delayed). By written agreement, this period may be further extended (which extension shall not be unreasonably withheld or delayed). Without limiting the foregoing, no publication or presentation shall be made unless and until the non-publishing or non-presenting Party ‘s reasonable comments on the proposed publication or presentation have been addressed and any information has been removed product that is determined by the non-publishing not a Product or non-presenting Party (b) Senti from making Publications with respect to be its Confidential Information or any Senti products that the non-publishing or non-presenting Party desires to maintain in secrecy to preserve the value of its rights under this Agreement. The Parties will each comply with standard academic practice regarding authorship of scientific publications or presentations and recognition of contribution of other Persons in any publications or presentations relating to do not incorporate a Licensed Product and/or Selected Compound or any discovery, research or Development activities under this AgreementPromoter.

Publication Rights. Each During the Term, the following restrictions shall apply with respect to possible disclosure by either Party of the other Party’s Confidential Information relating to Licensed Product in any publication or presentation. A Party (the “Publishing Party”) shall submit to provide the other Party with a copy of any proposed publication or presentation at least [***] days before submission for review and approval all proposed academic, scientific and medical publications and public presentations relating publication by the Publishing Party or its Affiliates so as to provide such other Party with an opportunity to recommend any activities under this Agreement for review in connection with preservation of Patent Rights and trade secrets or changes it reasonably believes are necessary to determine whether continue to maintain the Confidential Information should disclosed by the other Party to the Publishing Party in accordance with the requirements of this Agreement. The incorporation of such recommended changes shall not be modified or deleted from unreasonably refused; and if such other Party notifies (“Notice”) the Publishing Party in writing, within [***] days after receipt of the copy of the proposed publication or public presentation, that such publication or presentation in its reasonable judgment (a) contains an invention, solely or jointly conceived or reduced to practice by the other Party, for which the other Party reasonably desires to obtain patent protection or (b) could be expected to have a material adverse effect on the commercial value of any Confidential Information disclosed by the other Party to the Publishing Party, the Publishing Party shall prevent such publication or delay such publication for a mutually agreeable period of time. Written copies In the case of such proposed publications and presentations inventions, a delay shall be submitted for a period reasonably sufficient to permit the timely preparation and filing of a patent application(s) on such invention, and in no event less than [***] days after the date of the Notice. In the case of Confidential Information, any of the non-publishing or non-presenting Party no later than Party’s Confidential Information shall be deleted as requested. […***…] days before the planned submission for publication or presentation and the non-publishing or non-presenting Party shall provide its comments with respect to such publications and presentations within […***…] days after its receipt of such written copy. The review period may be extended for an additional […***…] days if the non-publishing or non-presenting Party can demonstrate a reasonable need for such extension including, without limitation, the preparation and filing of patent applications (which extension shall not be unreasonably withheld or delayed). By written agreement, this period may be further extended (which extension shall not be unreasonably withheld or delayed). Without limiting the foregoing, no publication or presentation shall be made unless and until the non-publishing or non-presenting Party ‘s reasonable comments on the proposed publication or presentation have been addressed and any information has been removed that is determined by the non-publishing or non-presenting Party to be its Confidential Information or that the non-publishing or non-presenting Party desires to maintain in secrecy to preserve the value of its rights under this Agreement. The Parties will each comply with standard academic practice regarding authorship of scientific publications or presentations and recognition of contribution of other Persons in any publications or presentations relating to a Licensed Product and/or Selected Compound or any discovery, research or Development activities under this Agreement].